Radius Health to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 12:01 pm UTC| Business
WALTHAM, Mass., Feb. 28, 2017 -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases,...
Radius Health to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 12:01 pm UTC| Business
WALTHAM, Mass., Feb. 28, 2017 -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases,...
Feb 28, 2017 12:01 pm UTC| Business
2016 net sales of $3.6 billion, an increase of 41.0%; record net sales of $950 million in Q4 2016FY and Q4 2016 organic sales increase of 2.0% and 4.6%, respectively2016 GAAP basic EPS loss of $0.14 or $0.63 fully...
Feb 28, 2017 12:01 pm UTC| Business
2016 net sales of $3.6 billion, an increase of 41.0%; record net sales of $950 million in Q4 2016FY and Q4 2016 organic sales increase of 2.0% and 4.6%, respectively2016 GAAP basic EPS loss of $0.14 or $0.63 fully...
Feb 28, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 28, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the company’s...
Feb 28, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 28, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the company’s...
Feb 28, 2017 12:01 pm UTC| Business
Allowed patent application claims methods for generating radioimmunoconjugates linked to Actinium-225Patent expected to expire in July 2030 NEW YORK, Feb. 28, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM)...